Two people infected with the same strain of COVID-19 can have vastly different experiences. One might never even sniffle, and ...
Researchers have uncovered a new way bacteria detect viral attacks: a virus-produced enzyme cuts a bacterial sensor protein, triggering a self-destructing immune response. The discovery could lead to ...
HIV is a virus that attacks the immune system, weakening the body’s ability to fight infections and disease. Although there ...
A new long-acting HIV treatment could expand options for people who have trouble taking daily pills and whose virus is ...
We are at the forefronts of fighting viral diseases that have global pandemic potential, presenting unmet medical needs, and ...
Lenacapavir is a long-acting antiretroviral medicine that has introduced a fundamentally different approach to HIV prevention ...
Fiji's government announced a national HIV emergency on September 15, 2026, saying the number of cases is estimated to have reached one in 60 Fijian adults, a 16-fold increase since 2019. Numerous ...
Small HIV trials suggest combinations of immune therapies may help some people control the virus without daily medication, although larger studies and sustained funding are still needed.
SHELTON, CT / ACCESS Newswire / October 5, 2026 / , Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader ...
Antibody Infusions Kept HIV in Check for Years in Some Patients, Helped by Their Own Immune Defenses
New RIO trial analysis shows two long-acting antibodies let some people with HIV stay off daily treatment for months or years ...
Doctors at San Francisco General Hospital's famed AIDS clinic have shown the immune system can be primed to keep the virus in ...
Around 12 per cent of the world’s total cancer cases in 2024 were likely caused by an infection, according to new research from the World Health Organization (WHO). The study, published last Tuesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results